Is CRISPR Therapeutics AG overvalued?

CRISPR Therapeutics AG (CRSP) — key valuation metrics and fundamentals.

No verdict

Price

$52.97

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$5.11B

Dividend yield

0.0%

Return on equity

-24.4%

Sector

Healthcare

Fair value compares CRSP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 17 Aug 2026.

Related stocks